Literature DB >> 15292123

The CcpA protein is necessary for efficient sporulation and enterotoxin gene (cpe) regulation in Clostridium perfringens.

John Varga1, Veronica L Stirewalt, Stephen B Melville.   

Abstract

Clostridium perfringens is the cause of several human diseases, including gas gangrene (clostridial myonecrosis), enteritis necroticans, antibiotic-associated diarrhea, and acute food poisoning. The symptoms of antibiotic-associated diarrhea and acute food poisoning are due to sporulation-dependent production of C. perfringens enterotoxin encoded by the cpe gene. Glucose is a catabolite repressor of sporulation by C. perfringens. In order to identify the mechanism of catabolite repression by glucose, a mutation was introduced into the ccpA gene of C. perfringens by conjugational transfer of a nonreplicating plasmid into C. perfringens, which led to inactivation of the ccpA gene by homologous recombination. CcpA is a transcriptional regulator known to mediate catabolite repression in a number of low-G+C-content gram-positive bacteria, of which C. perfringens is a member. The ccpA mutant strain sporulated at a 60-fold lower efficiency than the wild-type strain in the absence of glucose. In the presence of 5 mM glucose, sporulation was repressed about 2,000-fold in the wild-type strain and 800-fold in the ccpA mutant strain compared to sporulation levels for the same strains grown in the absence of glucose. Therefore, while CcpA is necessary for efficient sporulation in C. perfringens, glucose-mediated catabolite repression of sporulation is not due to the activity of CcpA. Transcription of the cpe gene was measured in the wild-type and ccpA mutant strains grown in sporulation medium by using a cpe-gusA fusion (gusA is an Escherichia coli gene encoding the enzyme beta-glucuronidase). In the exponential growth phase, cpe transcription was two times higher in the ccpA mutant strain than in the wild-type strain. Transcription of cpe was highly induced during the entry into stationary phase in wild-type cells but was not induced in the ccpA mutant strain. Glucose repressed cpe transcription in both the wild-type and ccpA mutant strain. Therefore, CcpA appears to act as a repressor of cpe transcription in exponential growth but is required for efficient sporulation and cpe transcription upon entry into stationary phase. CcpA was also required for maximum synthesis of collagenase (kappa toxin) and acted as a repressor of polysaccharide capsule synthesis in the presence of glucose, but it did not regulate synthesis of the phospholipase PLC (alpha toxin).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15292123      PMCID: PMC490932          DOI: 10.1128/JB.186.16.5221-5229.2004

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  43 in total

1.  Similar frequency of detection of Clostridium perfringens enterotoxin and Clostridium difficile toxins in patients with antibiotic-associated diarrhea.

Authors:  C Abrahao; R J Carman; H Hahn; O Liesenfeld
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-09       Impact factor: 3.267

2.  Genotyping of enterotoxigenic Clostridium perfringens fecal isolates associated with antibiotic-associated diarrhea and food poisoning in North America.

Authors:  S G Sparks; R J Carman; M R Sarker; B A McClane
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

3.  Identification of a novel locus that regulates expression of toxin genes in Clostridium perfringens.

Authors:  Kaori Ohtani; Sushanta K Bhowmik; Hideo Hayashi; Tohru Shimizu
Journal:  FEMS Microbiol Lett       Date:  2002-03-19       Impact factor: 2.742

Review 4.  The complex interactions between Clostridium perfringens enterotoxin and epithelial tight junctions.

Authors:  B A McClane
Journal:  Toxicon       Date:  2001-11       Impact factor: 3.033

5.  Catabolite repression mediated by the CcpA protein in Bacillus subtilis: novel modes of regulation revealed by whole-genome analyses.

Authors:  M S Moreno; B L Schneider; R R Maile; W Weyler; M H Saier
Journal:  Mol Microbiol       Date:  2001-03       Impact factor: 3.501

6.  Role of CcpA in regulation of the central pathways of carbon catabolism in Bacillus subtilis.

Authors:  S Tobisch; D Zühlke; J Bernhardt; J Stülke; M Hecker
Journal:  J Bacteriol       Date:  1999-11       Impact factor: 3.490

7.  Synergistic effects of alpha-toxin and perfringolysin O in Clostridium perfringens-mediated gas gangrene.

Authors:  M M Awad; D M Ellemor; R L Boyd; J J Emmins; J I Rood
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

8.  Emended descriptions of Clostridium acetobutylicum and Clostridium beijerinckii, and descriptions of Clostridium saccharoperbutylacetonicum sp. nov. and Clostridium saccharobutylicum sp. nov.

Authors:  S Keis; R Shaheen; D T Jones
Journal:  Int J Syst Evol Microbiol       Date:  2001-11       Impact factor: 2.747

9.  Proteome and transcriptome analysis of the virulence genes regulated by the VirR/VirS system in Clostridium perfringens.

Authors:  Takeshi Shimizu; Kensuke Shima; Ken-ichi Yoshino; Kazuyoshi Yonezawa; Tohru Shimizu; Hideo Hayashi
Journal:  J Bacteriol       Date:  2002-05       Impact factor: 3.490

10.  Identification of a co-repressor binding site in catabolite control protein CcpA.

Authors:  A Kraus; E Küster; A Wagner; K Hoffmann; W Hillen
Journal:  Mol Microbiol       Date:  1998-12       Impact factor: 3.501

View more
  44 in total

1.  Distinct time-resolved roles for two catabolite-sensing pathways during Streptococcus pyogenes infection.

Authors:  Colin C Kietzman; Michael G Caparon
Journal:  Infect Immun       Date:  2010-11-22       Impact factor: 3.441

Review 2.  How phosphotransferase system-related protein phosphorylation regulates carbohydrate metabolism in bacteria.

Authors:  Josef Deutscher; Christof Francke; Pieter W Postma
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

3.  Glucose-dependent activation of Bacillus anthracis toxin gene expression and virulence requires the carbon catabolite protein CcpA.

Authors:  Christina Chiang; Cristina Bongiorni; Marta Perego
Journal:  J Bacteriol       Date:  2010-10-22       Impact factor: 3.490

4.  Construction and characterization of a lactose-inducible promoter system for controlled gene expression in Clostridium perfringens.

Authors:  Andrea H Hartman; Hualan Liu; Stephen B Melville
Journal:  Appl Environ Microbiol       Date:  2010-11-19       Impact factor: 4.792

5.  Investigation into the role of catabolite control protein A in the metabolic regulation of Streptococcus suis serotype 2 using gene expression profile analysis.

Authors:  Xulong Lang; Zhonghai Wan; Ying Pan; Xiuran Wang; Xiaoxu Wang; Zhaoyang Bu; Jing Qian; Huazong Zeng; Xinglong Wang
Journal:  Exp Ther Med       Date:  2015-04-30       Impact factor: 2.447

Review 6.  Regulating the Intersection of Metabolism and Pathogenesis in Gram-positive Bacteria.

Authors:  Anthony R Richardson; Greg A Somerville; Abraham L Sonenshein
Journal:  Microbiol Spectr       Date:  2015-06

7.  A novel toxin regulator, the CPE1446-CPE1447 protein heteromeric complex, controls toxin genes in Clostridium perfringens.

Authors:  Nozomu Obana; Kouji Nakamura
Journal:  J Bacteriol       Date:  2011-07-01       Impact factor: 3.490

Review 8.  Sporulation and Germination in Clostridial Pathogens.

Authors:  Aimee Shen; Adrianne N Edwards; Mahfuzur R Sarker; Daniel Paredes-Sabja
Journal:  Microbiol Spectr       Date:  2019-11

9.  Carbon catabolite repression of type IV pilus-dependent gliding motility in the anaerobic pathogen Clostridium perfringens.

Authors:  Marcelo Mendez; I-Hsiu Huang; Kaori Ohtani; Roberto Grau; Tohru Shimizu; Mahfuzur R Sarker
Journal:  J Bacteriol       Date:  2007-11-02       Impact factor: 3.490

10.  A combination of independent transcriptional regulators shapes bacterial virulence gene expression during infection.

Authors:  Samuel A Shelburne; Randall J Olsen; Bryce Suber; Pranoti Sahasrabhojane; Paul Sumby; Richard G Brennan; James M Musser
Journal:  PLoS Pathog       Date:  2010-03-19       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.